$3.750
+0.051 (+1.35%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
SABS 相似图表分析预测
Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.73 (-0.54%). The 1-week path is $3.71 (-1.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 SAB Biotherapeutics Inc 股票吗？
SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.79, which is significantly lower than the average analyst price target of $12.75, suggesting a potential upside of over 235%. Additionally, the company has a strong cash position of $217.6 million, providing operational runway through 2028 despite recent losses. However, the main risk is the net loss of $22.49 million reported in Q2 2026, which highlights ongoing financial challenges.
SABS 股价于 Wednesday 收于 $3.75，此前上涨 +1.35%
SAB Biotherapeutics Inc (SABS) last closed at $3.75, gaining +1.35%. These facts feed the 1-day and 1-week SABS price prediction above.
预测驱动因素
SAB Biotherapeutics Inc（SABS）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 SABS 最接近的股票，按相似度排序。
SABS 季节性分析
Historically the probability of a positive September return for SABS is 0.00%. December offers the highest probability of a positive month at 37.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。